Clinical Trial Update: Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine. [Phase 2]

View source ↗

Summary

A Phase II trial evaluating the combination of pegylated liposomal doxorubicin and dexamethasone in immunocompetent patients with cerebral lymphoma that relapse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: University Hospital, Brest | Conditions: Cerebral Lymphoma B Cell Refractory | Phase 2 | Status: TERMINATED